Dose commonly discussed range | Cycle common use window | Time Off break between cycles | Notes context & cautions
01 Research Peptides
Peptide Injectable Dose Topical Dose Cycle Time Off Benefits Notes Blood Work Actions
FOX04-DR 10mg 0.25–0.5 mg/day sub-Q — 3-day cycles every 4–12 weeks 4+ weeks Senescent cell clearance, cellular rejuvenation, longevity Highly advanced; targets p53 to induce apoptosis in senescent cells; one of the most potent longevity compounds in research CBC, CMP, inflammatory markers (CRP, IL-6)
Ovagen 20mg 10–150 mcg/day sub-Q — 10-day cycles, 1–2x per year 3–6 months Liver tissue support, hepatic function, detoxification suppor Khavinson bioregulator targeting liver tissue; used in hepatic health and longevity protocols CMP, CBC, liver enzymes (ALT, AST, GGT)
Prostamax 20mg 0.5–1 mg/day sub-Q — 10-day cycles, 1–2x per year 3–6 months Prostate tissue support, male urinary and reproductive health Khavinson bioregulator targeting prostate tissue; relevant for aging male health protocols PSA, total testosterone, CMP
Testagen 20mg 100–300 mcg/day sub-Q — 10-day cycles, 1–2x per year 3–6 months Testicular tissue support, male hormonal function Khavinson bioregulator targeting testicular tissue; used in male longevity and hormonal support protocols Total/free testosterone, LH, FSH, CMP
Vesugen 20mg 0.5–2 mg/day sub-Q — 10-day cycles, 1–2x per year 3–6 months Vascular health, cardiovascular tissue support, circulation Khavinson bioregulator peptide targeting vascular tissue; part of Russian bioregulator series CMP, CBC, cardiovascular panel, blood pressure
PE-22-28 10mg Injectable: 50–200 mcg/day sub-Q. Nasal: per product label — 2–4 weeks 1–2 weeks Antidepressant activity, neuroplasticity, cognitive support Spadin analog; TREK-1 channel modulator; highly experimental Baseline CBC, CMP
P21 10mg Injectable: 100–300 mcg/day sub-Q — 2–4 weeks2–4 weeks 2–4 weeks Neurogenesis, cognitive enhancement, BDNF modulation CNTF analog; advanced/experimental; limited human data — research use only Baseline CBC, CMP
N-Acetyl Selank 10mg Nasal: 125–250 mcg per nostril 1–2x daily. Injectable: 250–500 mcg/day sub-Q — 2–4 weeks 1–2 weeks Anxiolytic, stress reduction, mood stabilization without sedation Acetylated form of Selank — longer-acting profile; often preferred over standard Selan Baseline CBC, cortisol optional
N-Acetyl Semax 10mg Nasal: 50–100 mcg per nostril 1–2x daily. Injectable: 200–500 mcg/day sub-Q — 2–4 weeks 1–2 weeks Enhanced focus, BDNF support, neuroprotection, mood Acetylated form of Semax — reported longer duration of action than standard Semax Baseline CBC, CMP
Kisspeptin-10 10mg 100–200 mcg/day sub-Q — 4–8 weeks 2–4 weeks Hormonal signaling, LH/FSH support, libido Used in fertility and hormonal optimization discussions LH, FSH, total testosterone, estradiol
Oxytocin 10mg Injectable: 100–500 mcg/day sub-Q. Intranasal: 8 IU per nostril per dose — As needed As needed Social bonding, mood, intimacy Intranasal standard; injectable faster onset Baseline CBC, CMP
Follistatin-344 10mg 50–100 mcg/day sub-Q or IM near target muscle — 10–30 days 4–6 weeks Muscle growth, myostatin inhibition Short cycles common; advanced and experimental FSH, LH, testosterone, CMP
IGF-1 LR3 1mg 20–50 mcg/day sub-Q — 4–6 weeks 4 weeks Muscle growth, recovery, satellite-cell activation Monitor blood glucose; higher-risk category IGF-1, fasting glucose, insulin, CMP
GHRP-6 5mg 100–300 mcg per injection sub-Q — 6–12 weeks 3–4 weeks GH release, appetite stimulation Significant hunger side effect; glucose and cortisol concerns IGF-1, cortisol, fasting glucose, prolactin
GHRP-2 5mg 100–300 mcg/day sub-Q — 6–12 weeks 3–4 weeks GH release, recovery, appetite effects More aggressive GH release; cortisol/prolactin increases possible IGF-1, cortisol, fasting glucose, prolactin
Sermorelin 5mg 200–500 mcg/day sub-Q — 8–16 weeks 3–4 weeks GH secretagogue, sleep, recovery More recognized in clinical wellness settings IGF-1, fasting glucose, cortisol
CJC-1295 DAC 5mg 0.3–1 mg per injection sub-Q — 8–12 weeks 3–4 weeks Longer-acting GH support Much lower frequency than no-DAC; do not treat them the same IGF-1, fasting glucose
SLU-PP-332 5mg 250 mcg/day sub-Q or per protocol — 4–8 weeks 2–4 weeks Metabolic support, exercise mimetic interest Highly experimental; limited human data —
5-Amino-1MQ 50mg 25–50 mg/day oral capsule — 4–8 weeks 2–4 weeks Energy, body composition, metabolic support Oral only; not injectable CMP, fasting glucose, lipid panel
HGH Frag 176-191 10mg 250–500 mcg/day sub-Q split 2x (fasted AM + pre-bed) — 4–12 weeks 2–4 weeks Fat metabolism, lipolysis Best fasted; no appetite stimulation unlike full GH Fasting glucose, IGF-1, CMP
AOD-9604 5mg 0.3–0.5 mg/day sub-Q — 4–12 weeks 2–4 weeks Fat-loss oriented use Best administered fasted; no topical standard Fasting glucose, IGF-1, CMP
Cagri + Sema Stack 5mg +5mg 0.25–2.4 mg/week each sub-Q — 8–16+ weeks 4–6 weeks Appetite control and fat-loss synergy Dose refers to each ingredient separately —
Cagrilintide 5mg 0.6–4.5 mg/week sub-Q — 12–24 weeks No standard time off Appetite suppression Usually stacked with sema in research settings HbA1c, fasting insulin, CMP, lipid panel
Semaglutide 10mg 0.25 mg/week → titrate to 0.5 → 1 → 1.7 → 2.4 mg/week sub-Q — 12–16+ weeks No fixed time off Appetite suppression, weight loss, glycemic support GI sides common on ramp-up; slow titration reduces nause Lipase, amylase, HbA1c, fasting insulin, thyroid panel, CMP
AHK-Cu Injectable: 1–2 mg/day sub-Q Topical: 1–5% solution 1–2x daily 4–8 weeks 2–4 weeks Hair growth, scalp health, skin quality, collagen support Copper peptide similar to GHK-Cu; strong focus on hair follicle research CMP baseline
ARA-290 2–4 mg/day sub-Q No standard topical use 4–8 weeks 2–4 weeks Neuroprotection, pain support, tissue repair, insulin sensitivity Erythropoietin analog; advanced/experimental; primarily research use CBC, CMP, HbA1c
Glow Per blend label; typically 1–2x daily Per blend label 4–6 weeks 2–4 weeks Skin, healing, cosmetic support Check ingredient breakdown for active amounts CMP, CBC
LL37 50–400 mcg/day sub-Q 50–100 mcg per application, 1–2x daily 2–6 weeks 2–4 weeks Antimicrobial and immune support Advanced/experimental; topical for wound and skin CBC, CMP, CRP
Thymalin Injectable: 100 mcg/day sub-Q for 10 days — 10-day cycles, 1–2x per year 3–6 months Immune system regulation, T-cell support, thymic function Synthetic dipeptide from thymopoietin; part of Russian bioregulator immune series CBC with lymphocytes, CRP, IL-6
Thymosin Alpha 0.3–0.5 mg/day sub-Q No standard topical use 4–12 weeks 4 weeks Immune modulation, inflammation support
One of the more documented immune peptides
CBC with lymphocytes, CRP, IL-6
BPC 10mg + TB 10 mg 0.5–1.5 mg/day sub-Q 500 mcg–1 mg BPC per application if topical blend 4–6 weeks 2–4 weeks Synergistic soft tissue support, inflammation reduction Verify exact mg per ingredient in your blend CMP, CBC
Glutathione Injectable: 100–200 mg/day sub-Q. IV: 400–1,200 mg IV or IM Nasal/topical: per product label 4–8 weeks 2–4 weeks Antioxidant support, detoxification, skin brightening, immune support
Master antioxidant; IV delivers fastest bioavailability; oral poorly absorbed CMP, CBC
CJC-1295 no DAC 5mg+ Ipa 5mg 00–300 mcg/day sub-Q — 8–12 weeks 3–4 weeks GH pulse, sleep, recovery, lean mass Inject 30–60 min before bed for best GH pulse —
Pinealon 20mg Injectable: 1–2 mg/day sub-Q. Nasal: per product label — 10-day cycles, 1–2x per year 3–6 months Neuroprotection, circadian rhythm support, cognitive longevity Khavinson bioregulator targeting pineal gland; part of the Russian bioregulator serie Baseline CBC, CMP
Ipamorelin 5mg 100–300 mcg/day sub-Q — 8–12 weeks 3–4 weeks GH pulse, sleep, recovery, lean mass Clean GH release; minimal cortisol/prolactin spike IGF-1, fasting glucose
GHK-CU 50mg 1–2 mg/day sub-Q 1–5% cream/serum, 1–2x daily 4–8 weeks 2–4 weeks Skin quality, wound support, hair suppor Topical most common; injectable for anti-aging/wound protocols CMP, copper/zinc optional
Epithalon 10mg 5–10 mg/day sub-Q or IV for 10 consecutive days — Every 6–12 months 3–6 months between cycles Telomere support, longevity, anti-aging Short burst cycles; popular in longevity circles CBC, CMP
Tirzepatide 10mg 2.5–15 mg/week sub-Q — 12–16+ weeks No fixed time off Weight loss, appetite control, metabolic support Stronger weight loss data than sema in head-to-head trials Lipase, amylase, HbA1c, fasting insulin, thyroid panel, CMP, lipid panel
SS-31 10mg 5–10 mg/day sub-Q — 4–8 weeks 2–4 weeks Mitochondrial protection, energy, cellular health, anti-aging Highly regarded in longevity circles; targets mitochondrial inner membrane directly —
NAD+ 500mg Injectable: 50–100 mg/day sub-Q. IV: 250–1,000 mg over 2–4 hrs. Oral: 250–500 mg/day — 4–12 weeks 2–4 weeks Energy, cognition, mitochondrial support IV fastest onset; sub-Q solid middle ground CMP, CBC, NAD+ levels (specialty lab)
KPV 10mg 200–500 mcg/day sub-Q 0.1–0.5% concentration, 1–2x daily 4–8 weeks 2–4 weeks GI support, inflammation control, skin calming Oral capsule form also discussed for gut use CMP, CRP
Tesamorelin 10mg 1–2 mg/day sub-Q — 12+ weeks Depends on goal Visceral fat reduction, GH-axis support FDA-approved dosing exists; don't mix formulation strengths IGF-1, fasting glucose, lipid panel, CMP
TB500 10mg 0.5–1 mg/day sub-Q Not commonly used topically 4–8 weeks 2–4 weeks Recovery, mobility, tissue repair
Often stacked with BPC-157
CBC, CMP
Semax 11mg Injectable: 0.3–0.8 mg/day sub-Q. Intranasal: 50–100 mcg per nostril, 1–3x daily — 2–4 weeks 1–2 weeks Focus, cognition, neuro-support, mood Intranasal most common route Baseline CBC, CMP
Selank 11mg Injectable: 0.3–0.5 mg/day sub-Q. Intranasal: 125–250 mcg per nostril, 1–3x daily — 2–4 weeks 1–2 weeks Calm focus, anxiety support, mood Often paired with Semax Baseline CBC, cortisol optiona
PT 141 10mg Injectable: 0.5–1.5 mg/day sub-Q. Intranasal: 1–2 mg per dose — As needed needed As needed Libido and sexual function support Start at 0.5–1 mg; nausea is common CBC, CMP, blood pressure baseline
Retatruide 2–12 mg/week sub-Q — 24–48+ weeks No standard cycling model Triple agonist; fat loss, metabolic support Still investigational; GI effects and elevated heart rate noted Lipase, amylase, HbA1c, fasting insulin, thyroid panel, CMP, lipid panel
MOTS-C 10mg 200–1000 mcg/day sub-Q — 4–8 weeks 2–4 weeks Metabolic and mitochondrial support Also fits under metabolic health section CMP, fasting glucose, HbA1c, CBC
BPC-157 10mg 200–600 mcg/day sub-Q 500 mcg–1 mg per application, 1–2x daily 4–8 weeks 2–4 weeks Gut support, tendon/ligament healing, tissue repair Topical for surface wounds; injectable near injury preferred CMP, CBC
02 Beauty & Vitality
Peptide Injectable Dose Topical Dose Cycle Time Off Benefits Notes Blood Work Actions
BPC-157 10mg 200–600 mcg/day sub-Q 500 mcg–1 mg per application, 1–2x daily 4–8 weeks 2–4 weeks Gut support, tendon/ligament healing, tissue repair Topical for surface wounds; injectable near injury preferred CMP, CBC
03 Cognitive & Daily Wellness
Peptide Injectable Dose Topical Dose Cycle Time Off Benefits Notes Blood Work Actions
BPC-157 10mg 200–600 mcg/day sub-Q 500 mcg–1 mg per application, 1–2x daily 4–8 weeks 2–4 weeks Gut support, tendon/ligament healing, tissue repair Topical for surface wounds; injectable near injury preferred CMP, CBC
04 Longevity & Anti-Aging
Peptide Injectable Dose Topical Dose Cycle Time Off Benefits Notes Blood Work Actions
BPC-157 10mg 200–600 mcg/day sub-Q 500 mcg–1 mg per application, 1–2x daily 4–8 weeks 2–4 weeks Gut support, tendon/ligament healing, tissue repair Topical for surface wounds; injectable near injury preferred CMP, CBC
05 Performance & Recovery
Peptide Injectable Dose Topical Dose Cycle Time Off Benefits Notes Blood Work Actions
BPC-157 10mg 200–600 mcg/day sub-Q 500 mcg–1 mg per application, 1–2x daily 4–8 weeks 2–4 weeks Gut support, tendon/ligament healing, tissue repair Topical for surface wounds; injectable near injury preferred CMP, CBC